Editas Medicine, Inc (EDIT) insider trading
Every open-market stock purchase and sale by Editas Medicine, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Gilmore Neil O'Neill (CEO) and 2 others sold $34K in the last 90 days.
- Last insider buy: Jessica Hopfield (Director), $254K, 2 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $107K (14 sales). Last close $2.51 on Oct 21, 2026.
Recent EDIT insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 8, 2026 | Daniel Scott Ory (C-suite exec) | Bought (not open market) | — |
| Sep 3, 2026 | Gilmore Neil O'Neill (CEO) | Sold | $15.6K |
| Sep 3, 2026 | Linda Burkly (C-suite exec) | Sold | $2.2K |
| Sep 3, 2026 | Amy Parison (CFO) | Sold | $1.4K |
| Aug 6, 2026 | Patrick Thomas Ellinor II (Director) | Bought (not open market) | — |
| Aug 3, 2026 | Amy Parison (CFO) | Sold | $1.7K |
| Jul 28, 2026 | Linda Burkly (C-suite exec) | Sold | $13.2K |
| Jun 17, 2026 | Elliott M. Levy (Director) | Bought (not open market) | — |
| Jun 17, 2026 | David Scadden (Director) | Bought (not open market) | — |
| Jun 17, 2026 | Andrew Hirsch (Director) | Bought (not open market) | — |
| Jun 17, 2026 | Jessica Hopfield (Director) | Bought (not open market) | — |
| Jun 17, 2026 | Bernadette Connaughton (Director) | Bought (not open market) | — |
| Jun 3, 2026 | Gilmore Neil O'Neill (CEO) | Sold | $41.5K |
| Jun 3, 2026 | Linda Burkly (C-suite exec) | Sold | $2K |
| Jun 3, 2026 | Amy Parison (CFO) | Sold | $1.3K |
| Mar 12, 2026 | Amy Parison (CFO) | Bought (not open market) | — |
| Mar 12, 2026 | Linda Burkly (C-suite exec) | Bought (not open market) | — |
| Mar 12, 2026 | Gilmore Neil O'Neill (CEO) | Bought (not open market) | — |
| Mar 3, 2026 | Gilmore Neil O'Neill (CEO) | Sold | $10.9K |
| Mar 3, 2026 | Linda Burkly (C-suite exec) | Sold | $1.5K |
| Mar 3, 2026 | Amy Parison (CFO) | Sold | $957 |
| Dec 3, 2025 | Gilmore Neil O'Neill (CEO) | Sold | $12.1K |
| Dec 3, 2025 | Linda Burkly (C-suite exec) | Sold | $1.5K |
| Dec 3, 2025 | Amy Parison (CFO) | Sold | $993 |
Who's trading EDIT
- Daniel Scott Ory, C-suite exec: other filings, last Sep 8, 2026
- Gilmore Neil O'Neill, CEO: sold $80.1K (4 sales), last Sep 3, 2026
- Amy Parison, CFO: sold $6.3K (5 sales), last Sep 3, 2026
- Linda Burkly, C-suite exec: sold $20.3K (5 sales), last Sep 3, 2026
- Patrick Thomas Ellinor II, Director: other filings, last Aug 6, 2026
- Andrew Hirsch, Director: other filings, last Jun 17, 2026
- Jessica Hopfield, Director: other filings, last Jun 17, 2026
- Elliott M. Levy, Director: other filings, last Jun 17, 2026
- Bernadette Connaughton, Director: other filings, last Jun 17, 2026
- David Scadden, Director: other filings, last Jun 17, 2026
Get free alerts when an insider at Editas Medicine, Inc files a new trade →